CD4 and COVID-19: The current median value of the CD4 count of our cohort was below the aforementioned threshold of 350 cells/μL, and the nadir of CD4 was very low; nevertheless, they seemed to be less affected by severe COVID-19 manifestations than non-HIV-infected patients with a broadly similar mortality rate.